Strata, Kosmo Meditech expand partnership for Korean product distribution

Key takeaways:

• The agreement expands the companies’ distribution agreement through 2026.
• Annual and quarterly performance-based purchase requirements are established in the deal.

Strata Skin Sciences has expanded a distribution agreement with Kosmo Meditech for both direct capital sales and direct recurring revenue sales in Korea, according to a press release.

Strata develops and markets dermatologic products such as the XTRAC excimer laser, VTRAC lamp systems and the TheraClearX Acne Therapy System. Kosmo Meditech distributes these and other dermatologic products throughout Korea.

The expanded agreement between the two companies, which became effective on Jan. 1, extends the companies’ agreement through 2026 and defines annual and quarterly performance-based purchase requirements.

“This agreement not only signifies the strength and growth of the partnership between Strata and Kosmo, but also reinforces Strata’s dedication to upholding the highest standards in product and service offerings for dermatologic treatments worldwide,” Dolev Rafaeli, PhD, president and CEO of Strata, said in the release. “Korea continues to present a significant opportunity for us, leveraging Kosmo’s extensive in-country distribution network. This ongoing collaboration allows us to provide our customers with innovative therapeutic solutions while ensuring a framework for sustainable growth and market leadership.”